Takeda Pharmaceutical has agreed to divest its its majority shareholding of 51.34% in Guangdong Techpool Bio-Pharma (Techpool), a China-based firm focused on urinary protein biopharmaceuticals and production of biopharmaceuticals in critical care, to its joint […]
Chinese firm WuXi Biologics has announced a S$80m ($60m) investment to set up an a biologics manufacturing facility in Singapore. The Singapore Economic Development Board is supporting the development of new facility, which is […]
Two pharmaceutical companies, BioMarin and Spark, have announced positive results of their separate phase 1/2 studies of treatments for haemophilia A and haemophilia B, suggesting gene therapies may be able to transform how the disorder […]
The US Food and Drug Administration (FDA) has approved global biopharmaceutical company AstraZeneca’s Lokelma, formerly known as ZS-9, a drug designed to treat hyperkalaemia, on the third attempt. Patients with hyperkalaemia have high levels […]
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) are separately investigating the preliminary results from a study of babies born to Botswanan women infected with the human immunodeficiency virus (HIV), […]